Hewlett Packard Enterprise (NYSE: HPE) today announced that Frank D’Amelio, former executive vice president and CFO of Pfizer Inc., has been appointed to HPE’s Board of Directors, effective today. D’Amelio will also serve as a member of the Board’s Audit Committee.
D’Amelio’s expertise and proven leadership in finance, corporate development, and operations across multiple industries will bring additional valuable perspective to the Board, and his experience managing IT will lend a relevant customer lens to his insights.
“Frank has an impressive track record of driving a strategic vision for companies’ financial success and guiding large-scale transformations,” said Patricia Russo, chair of the Board of Directors, Hewlett Packard Enterprise. “HPE will benefit from his executive leadership experience and deep expertise across finance, corporate development, operations, IT, and supply chain as the company continues to drive performance and increase market differentiation.”
D’Amelio is a distinguished leader who has been regularly named one of America’s top CFOs. During his tenure as CFO at Pfizer, he was instrumental in leading a multi-year transformation and increased the company’s market capitalization by approximately $165 billion. In addition to his role as CFO at Pfizer, D’Amelio was also responsible for Global Supply from 2018 to 2021, which included the manufacturing and distribution of the COVID-19 vaccine.
Prior to joining the healthcare sector at Pfizer, D’Amelio worked in senior executive roles in the communications industry, including serving as Chief Operating Officer, Chief Administrative Officer, and Chief Financial Officer during his tenure at Lucent Technologies, Inc., which merged with Alcatel S.A. in 2006 to form Alcatel-Lucent.
“HPE’s differentiated edge-to-cloud strategy and portfolio are well-positioned to meet the needs of customers and continue to propel the company’s transformation and success,” D’Amelio said. “I am delighted to join the Board during this exciting period as HPE accelerates its leadership.”
D’Amelio also currently serves as a board director for Humana, Inc. and Zoetis, Inc.